Portland, OR, July 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global diabetic nephropathy market was estimated at $1.9 billion in 2021 and is anticipated to accrue a sum of $3.3 billion by 2031, registering a CAGR of 6.0% from 2022 to 2031. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and varying market trends.
Growing incidence of diabetic nephropathy, increase in number of people suffering from chronic kidney diseases, diabetes, hypertension and atherosclerosis and rise in awareness regarding diabetes and kidney-related disorders drive the growth of the diabetic nephropathy market. On the other hand, factors such as lack of skilled professionals for the treatment of diabetic nephropathy in emerging and less developed countries, poor planning of diabetic nephropathy treatments in low-income countries and strict regulatory rules regarding selling and lengthy approval time of drugs for diabetic nephropathy impede the growth of the market. However, rise in R&D investments in drug discovery and introduction of new medicines for diabetic nephropathy in developing nations are anticipated to create lucrative opportunities in the industry.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/16978
Covid-19 scenario-
- The Covid-19 pandemic impacted the global diabetic nephropathy market negatively because most priority was given to Covid-19 patients for treatment. Many medical colleges and hospitals were restructured to accommodate more patients diagnosed with Covid-19.
- Discovery and development of diabetic nephropathy medicines also slowed down during the pandemic, but did not come to a halt.
Get detailed COVID-19 impact analysis on the Diabetic Nephropathy Market - https://www.alliedmarketresearch.com/request-for-customization/16978?reqfor=covid
The global diabetic nephropathy market is analyzed across drugs class, type, distribution channel, and region.
Based on drugs class, the angiotensin-converting enzyme inhibitors segment contributed to nearly one-third of the total market revenue in 2021, and is projected to lead the trail by 2031. The diuretics segment, on the other hand, would exhibit the fastest CAGR of 7.4% during the forecast period.
Based on type, the Type-2 diabetes segment was the largest in 2021, accounting for nearly four-fifths of the total market revenue, and is projected to lead the trail by 2031. The same segment would exhibit the highest CAGR of 6.4% during the forecast period.
Based on region, the market across North America held the major share in 2021, garnering more than two-fifths of the global market. The Asia-Pacific region would manifest the fastest CAGR of 7.3% throughout the forecast period. The other provinces studied in the report include Europe and LAMEA.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/16978
The key market players analyzed in the global diabetic nephropathy market report include Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bayer Ag, Eli Lilly and Company, Merck & Co, Inc., Novartis Ag, Pfizer Inc., Reata Pharmaceuticals, Inc., and Sanofi. These market players have adhered to several strategies including partnership, expansion, collaboration, joint ventures, and others to prove their flair in the industry.
We also Offers Regional and Country Reports-
- Japan Diabetic Nephropathy Market
- South Korea Diabetic Nephropathy Market
- Singapore Diabetic Nephropathy Market
- Europe Diabetic Nephropathy Market
- Indonesia Diabetic Nephropathy Market
- Australia Diabetic Nephropathy Market
- Taiwan Diabetic Nephropathy Market
- US Diabetic Nephropathy Market
Trending Reports in Healthcare Industry-
Smart Inhalers Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Orthopedic Implants Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
3D Printed Drugs Market- Global Opportunity Analysis and Industry Forecast, 2020–2030
Wearable Injectors Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Computed Tomography (CT) Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Empty Capsules Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
